Tibia metastasis without Prostate Specific Antigen (PSA) increase following radical vesiculo-prostatectomy

被引:5
作者
Hübler J. [1 ]
Sükösd F. [2 ]
Czipri M. [3 ]
机构
[1] Department of Urology, University Medical School, Pécs
[2] Department of Pathology, University Medical School, Ṕecs
[3] Departments of Orthopedic Surgery, University Medical School, Ṕecs
关键词
Follow-up; Metastasis; Prostate carcinoma; PSA (prostate specific antigen); Radical prostatectomy;
D O I
10.1023/A:1007142910479
中图分类号
学科分类号
摘要
Objectives: PSA is regarded as the best method in the follow-up of prostate carcinoma. After radical vesiculo-prostatectomy the prostate carcinoma seldom recurs at zero or nearly zero PSA levels. Methods: The authors have used PSA since 1989 and they have found only one case where metastasis in the tibia came without an increase in PSA levels. Results: Tibia metastasis showed lower tissue activity of PSA than did the primary tumor in the prostate. The authors think this explains the zero PSA level when the metastasis developed. Conclusions: The authors think based on their case that PSA free progression prostate cancers may cases where the metastases do not produce PSA.
引用
收藏
页码:281 / 284
页数:3
相关论文
共 6 条
[1]  
Partin A.W., Pound C.R., Clemens J.Q., Epstein J.I., Walsh P.C., Serum PSA in anatomic radical prostatectomy: The Johns Hopkins experience after 10 years, Urol Clin North Am, 20, pp. 713-725, (1993)
[2]  
Aihara M., Lebovitz R.M., Wheeler T.M., Kinner B.M., Ohori M., Scardino P.T., Prostate specific antigen and Gleason grade: An immunohistochemical study of prostate cancer, J Urol, 151, pp. 1558-1564, (1994)
[3]  
Goldrath D.E., Messing E.M., Prostate specific antigen not detectable despite tumor progression after radical prostatectomy, J Urol, 142, pp. 1082-1084, (1989)
[4]  
Hudson M.A., Bahnson R.B., Catalona W.J., Clinical use of prostate specific antigen in patients with prostate cancer, J Urol, 142, pp. 1011-1017, (1989)
[5]  
Leibmann B.D., Ozdal D., Wheeler T.M., Scardino P.T., Distant metastasis after radical prostatectomy in patients without an elevated serum prostate antigen level, Cancer, 76, pp. 2530-2534, (1995)
[6]  
Takayama T.K., Krieger J.N., True L.D., Lange P.H., Recurrent prostate cancer despite undetectable prostate specific antigen, J Urol, 148, pp. 1541-1542, (1992)